Most data on US opioid-related deaths come from adults, but a recent study shows pediatric opioid deaths are on the rise at an alarming rate.
STIs in Adolescents and Young Adults: Trends, Management, More
Details on educational gaps, vaccination rates, and the importance of an open dialogue between patients and clinicians, here.
Children with HTN Have 2-times Higher Risk of Major Adverse Cardiac Events, According to New Research
Findings suggest that optimizing care for children with hypertension may reduce the risk of adult CVD, report researchers.
Nirsevimab for RSV Reduces Infant Hospitalizations by 82% in Real-World Study
In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).
FDA Approves Benralizumab as Add-On Maintenance Therapy for Children with Severe Asthma: Daily Dose
Your daily dose of the clinical news you may have missed.
Primary Care-Based Injury Prevention Program Reduces Pediatric Injuries: Daily Dose
FDA Approves Benralizumab as Add-On Maintenance Therapy for Children Aged 6-11 Years with Severe Asthma
The additional indication for benralizumab was supported by data from the phase 3 TATE trial.